Clinical and biochemical parameters of COVID-19 patients with prior or active dengue fever.

Authors:
Teotônio IMSN; de Carvalho JL; Castro LC; Nitz N; Hagström L and 4 more

Journal:
Acta Trop

Publication Year: 2020

DOI:
10.1016/j.actatropica.2020.105782

PMCID:
PMC7698682

PMID:
33259817

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Trop

Abbreviation: Acta Trop

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Tropical Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
A novel sensitive hexaplex high-resolution melt assay for identification of five human Plasmodium s…
Srisutham S; Rattanakoch P; Kijprasong K and 5 more (2023) - Transparency Score: 4/6
Challenges in the treatment and prevention of monkeypox infection; A comprehensive review.
Nyame J; Punniyakotti S; Khera K and 3 more (2023) - Transparency Score: 2/6
Peptide microarray analysis of in-silico predicted B-cell epitopes in SARS-CoV-2 sero-positive heal…
Vengesai A; Naicker T; Midzi H and 6 more (2022) - Transparency Score: 4/6
Seroprevalence of SARS-CoV-2 on health professionals via Bayesian estimation: a Brazilian case stud…
Maior CBS; Lins ID; Raupp LS and 6 more (2022) - Transparency Score: 3/6
Text mining in mosquito-borne disease: A systematic review.
Ong SQ; Pauzi MBM; Gan KH. (2022) - Transparency Score: 2/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025